We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
About Biomedical Basics
Biomedical Basics are AI-generated explanations prepared with access to the complete collection, human-reviewed prior to publication. Short and simple, covering biomedical and life sciences fundamentals.
Topics Covered
- RTK structure and function
- RTK activation mechanisms
- Major MAPK and PI3K pathways
- Key growth factors EGF and insulin
- RTKs in development and disease
- RTK dysregulation in cancer
- Therapeutic targeting of RTKs
Talk Citation
(2026, February 26). Tyrosine kinase receptors and growth factors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 18, 2026, from https://doi.org/10.69645/MISH3020.Export Citation (RIS)
Publication History
- Published on February 26, 2026
Financial Disclosures
A selection of talks on Cell Biology
Transcript
Please wait while the transcript is being prepared...
0:00
The following
session we'll cover
tyracine kinase receptors
and growth factors,
focusing on the structure
and function of
tyracine kinase receptors, RTKs,
how they transmit
external signals through
ligand induced dimerization
and activation,
and the major intracellular
pathways they initiate,
such as MAPK and PI three
K. We will examine the roles
of key growth factors like
EGF and insulin and
explore how RTK
signaling governs
crucial cellular
decisions in development
and adult physiology.
Finally, we will discuss
the consequences of
RTK dysregulation in diseases
like cancer and consider
the therapeutic potential
of targeting RTKs.
Tyracine kinase receptors,
often called RTKs,
are key regulators of
cellular communication.
These transmembrane
proteins consist
of an extracellular
ligand binding domain,
a single transmembrane
alpha helix,
and an intracellular
tyrosine kinase domain,
which transfers
phosphate groups from
ATP to specific
tyrosine residues.
RTKs interpret
external signals like
growth factors and convert
them into cellular responses.
Malfunctioning RTKs
can contribute
to diseases such as cancer,
making them important
therapeutic targets.
Activation of tyracine
kinase receptors
begins with ligand binding,
often a growth factor to
the extracellular domain.
This induces receptor
dimerisation,
bringing two kinase domains
together for
autophosphorylation,